iReminder’s white paper highlights key developments in HPV vaccine compliance and marketing efforts

Mar 11 2010

Automated reminder and follow-up calls for HPV vaccinations increase adherence rates from 5% to over 20%, according to a new white paper published by iReminder, LLC. The Scotland National Health Service is the leader in HPV vaccination compliance, with rates as high as 92% for the first dose and 87.8% for the second dose. The laggard is Mississippi, USA where HPV vaccination rates are as low as 15.8%.

“Based on this extensive global review, we compiled a list of best practices for designing compliance programs”

iReminder’s HPV Vaccination Compliance white paper highlights key developments in HPV vaccine compliance and marketing efforts. It provides guidance to pharmaceutical brand managers, managed care organizations, and Immunization Information Systems. The white paper includes best practices employed to help patients complete the three-dose HPV vaccinations. Many of these practices also are effective for a wide range of adherence programs.

Market data for Merck’s GARDASIL® and GlaxoSmithKline’s CERVARIX® are included, as well as an overview of the pipeline for HPV vaccines. Compliance programs in the U.S., UK, Scotland, Switzerland, Finland, Germany and Australia are described in detail.

“Based on this extensive global review, we compiled a list of best practices for designing compliance programs,” observed Jean Steckler, senior vice president of iReminder. Successful adherence programs provided personalized reminders, delivered at the patient’s preferred time and method,” she added.

Best practices include:

• A system that offers multiple enrollment locations, such as a physician’s office, clinic or pharmacy
• Escalation of reminder calls to patients who do not come in for their dose
• Programs specifically designed for ethnic groups
• Multi-lingual messages
• Global reach for phone, SMS and email reminders and follow-up contacts
• Patient compliance tracking